Search bioRxiv⌕ Search

bioRxiv · 10.1101/2023.03.07.531463

A systematic review on leptospirosis in cattle: a European perspective

Abstract

BackgroundLeptospirosis is a zoonotic disease which is globally distributed. Bovine leptospirosis often results in economic losses through its severe impact on reproduction performance. However, a clear overview of the disease characteristics in European cattle is lacking. The objective of this review was to summarise the current knowledge and state of the research on the epidemiology of bovine leptospirosis in Europe. MethodologyWe conducted a systematic literature review following the PRISMA guidelines. We screened four electronic databases (Pubmed, Web of Science, Scopus, CABI) and included studies published between 2001 and 2021, in English, German, and French. Identified papers were filtered according to predefined inclusion and exclusion criteria. ResultsSixty-two studies were included. Reported seroprevalences were remarkably variable among studies, probably reflecting local variations but also heterogeneity in the study designs, laboratory methods, and sample sizes. The five most reported circulating serogroups in European cattle were Sejroe, Australis, Grippotyphosa, Icterohaemorrhagiae, and Pomona. Abortion and fertility disorders were the most frequently reported signs of leptospirosis in European cattle and were generally associated with chronic infections. The acute form primarily affected juveniles and foetuses. Risk factors positively associated with leptospirosis in cattle were diverse, related to environmental (e.g. geographic location), climatic (e.g. flooding), and medical (e.g. presence of other diseases) parameters, as well as farming practices (e.g. purchase policy, herd size) and individual factors (e.g. animal age and breed). ConclusionsClinical features of bovine leptospirosis in Europe cover a large range of signs and confirmation of infection requires laboratory tests. The epidemiology of the disease is very local, most probably influenced by context-specific factors. This work highlights several research gaps, including a lack of research data from several countries, a lack of methodological harmonisation, a lack of large-scale studies, an underrepresentation of beef herds in the studies, and a lack of molecular investigations. Author SummaryLeptospirosis is a zoonotic disease that has been reported in cattle worldwide. This review systematically evaluated the available literature (2001-2021) on (i) the methods of diagnostics, (ii) (sero)prevalence, (iii) circulating serogroups/serovars, (iv) clinical signs, (v) and risk factors associated with leptospirosis in European cattle. We found that the prevalence of the disease was very variable among studies. Similarly, a wide range of clinical signs were described, but the most frequently reported ones were abortion and fertility disorders. Risk factors of infection in cattle included herd size, purchase of animals, access to pasture and natural water sources, contact with other animal species, presence of other diseases on farm, animal age, and occurrence of extreme weather events. This review highlights that leptospirosis should be considered as a differential diagnosis in case of abortion or reproductive failure in European cattle and emphasises the need for integrated disease prevention and control measures at farm or regional level. We identified several research gaps, particularly a lack of research data from several countries, a lack of large-scale studies, an underrepresentation of beef herds, and a limited use of molecular tools in the studies.

Source connections

Explore related subjects

Keep this discovery

Explore connections, maps & timelines

BibTeXRIS

Sohm, C., Steiner, J., Jöbstl, J., Wittek, T., Firth, C., Steinparzer, R., Desvars-Larrive, A.. 2023-03-07. A systematic review on leptospirosis in cattle: a European perspective. https://doi.org/10.1101/2023.03.07.531463

Cite the original work for its findings. Save a collection to share your selection of sources.

KEEP EXPLORING

Related preprints

A conserved cysteine-histidine-glutamate metal site identifies DUF501 (Rv1025), an essential uncharacterised protein family of Mycobacterium tuberculosis, as a candidate metalloenzyme and drug target

A substantial fraction of the Mycobacterium tuberculosis proteome remains functionally uncharacterised. Rv1025, a 155-residue protein carrying the domain of unknown function DUF501 (Pfam PF04417), is essential by transposon mutagenesis and vulnerable by CRISPR interference, an attractive but neglected drug target, yet has never been functionally described. The family (4,370 proteins, no Gene Ontology term, no solved structure) is uncharacterised across all organisms and essential in three Actinobacterial genera. A Foldseek search of the AlphaFold model against complete structural databases finds no significant homolog, indicating a novel fold. The operon eno-divIC-Rv1025-ppx2 is conserved across the Actinobacteria phylum, yet AlphaFold-Multimer finds no direct complex between Rv1025 and its neighbour DivIC. Instead, conservation across 8,700 homologous sequences reveals a near-invariant Cys113-His115-Glu59 cluster forming a pocket. Holo AlphaFold3 predictions with Zn, Fe and Mn confidently place a divalent metal on this triad at 2.25-2.47 A; mutating the triad relocates the metal, and an independent backbone-geometry predictor recovers the same site, confirming specificity. The triad is universal across the family: present in all 1,472 near-complete bacterial sequences of the Pfam alignment, with no non-conservative substitution among the 2,228 sequences examined, a defining feature of bacterial DUF501 rather than a mycobacterial peculiarity. We propose that DUF501 is a metal-binding protein and candidate metalloenzyme, the first functional hypothesis for this family, whose conserved, essential metal pocket is a promising drug target. As the predictions build on a conservation-defined site within a fully computational study, they are supportive rather than proof of metal occupancy and warrant experimental validation.

microbiology↗

Mycoplasmal endosymbionts of Trichomonas vaginalis are associated with reduced risk for Chlamydia trachomatis endometrial infection in asymptomatic, coinfected, women.

Trichomonas vaginalis is a protozoan parasite that causes trichomoniasis, the most common curable non-viral sexually transmitted infection, and Chlamydia trachomatis is a bacterial pathogen that can ascend to the upper genital tract and cause pelvic inflammatory disease, infertility, and ectopic pregnancy. T. vaginalis harbors bacterial endosymbionts, including Candidatus Malacoplasma girerdii, an obligate symbiont, and Metamycoplasma hominis, which can live freely or symbiotically. In a 16S rRNA sequencing study of the cervicovaginal microbiome of women at high risk for chlamydial infection, Ca. M. girerdii abundance was one of 13 features predicting lack of chlamydial spread to the endometrium, despite no direct association between T. vaginalis infection and reduced chlamydial ascension. Investigating the relationship between these microorganisms further, we found that T. vaginalis vaginal abundance correlated positively with chlamydial burden in women whose infection was confined to the cervix, while a nonsignificant inverse relationship was seen in women with endometrial spread. Among participants with high chlamydial burden, Ca. M. girerdii was detected exclusively in women without endometrial infection. Both endosymbionts trended toward more frequent detection, and higher abundance, in coinfected women without endometrial spread, while M. hominis abundance correlated strongly with T. vaginalis burden in this group. These findings suggest that mycoplasmal endosymbionts of T. vaginalis, rather than T. vaginalis itself, are microbial factors limiting chlamydial ascension, and point to a three-way interaction between parasite, endosymbiont, and bacterial pathogen that shapes upper genital tract C. trachomatis infection risk.

microbiology↗

Understanding the physiological alterations of Vibrio cholerae upon exposure to L-ascorbic acid

The scourge of cholera remains a major global public health threat. It affects up to 4 million people worldwide and causes tens of thousands of deaths each year. The disease is experiencing a concerning resurgence in many parts of Africa, the Middle East, and Asia. To effectively tackle cholera and circumvent rising antimicrobial resistance, targeted biological and preventive approaches, complementing traditional rehydration, are urgently needed. In this regard, our group has demonstrated the efficacy of L-ascorbic acid in controlling the growth and pathogenesis of Vibrio cholerae in vitro. The present work further provides a mechanistic elucidation of the L-ascorbic acid-mediated physiological changes in V. cholerae and also bolsters such a non-antibiotic approach to control cholera.

microbiology↗